Indication
Open-angle Glaucoma
7 clinical trials
12 products
Clinical trial
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint Comparing Generic Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® (Bimatoprost Ophthalmic Solution) 0.01% in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both EyesStatus: Not yet recruiting, Estimated PCD: 2025-03-01
Product
LUMIGANProduct
LumiganProduct
AGN-193408Clinical trial
A Phase 1/2 Study to Evaluate the Safety and Efficacy of AGN-193408 SR in Participants With Open-Angle Glaucoma or Ocular HypertensionStatus: Recruiting, Estimated PCD: 2027-08-30
Product
BimatoprostProduct
AR-12286Clinical trial
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 MonthsStatus: Completed, Estimated PCD: 2013-04-01
Product
Tafluprost + TimololProduct
TafluprostClinical trial
A Randomized, Double-masked, Controlled Parallel Group, Multi-center Study of DE-111A (Fixed Dose Combination of Tafluprost and Timolol Eye Drops) on the Treatment of Open Angle Glaucoma or Ocular Hypertension (With Tafluprost Eye Drops as a Comparator)Status: Completed, Estimated PCD: 2023-04-04
Product
PER-001Clinical trial
A Phase 1/2a Study to Evaluate Safety, Tolerability, and Pharmacodynamic Effect After Single Administration of PER-001 Intravitreal Implant in Participants With Open-Angle GlaucomaStatus: Recruiting, Estimated PCD: 2024-08-30
Clinical trial
Effect of MEMOPTIC on Visual Field of Patients Followed for a Chronic Open-angle GlaucomaStatus: Recruiting, Estimated PCD: 2023-08-01
Product
MEMOPTICProduct
Glaucoma